Citations for
1PRSS3
Small molecule inhibitors of mesotrypsin from a structure-based docking screen.
Kayode O, Huang Z, Soares AS, Caulfield TR, Dong Z, Bode AM, Radisky ES.
PLoS One 12(5):e0176694. doi: 10.1371/journal.pone.0176694. eCollection 2017. 2017
2PRSS3, TFPI2
PO-44 - Tissue factor pathway inhibitor-2 (TFPI-2) is cleaved by PRSS3: implication for tumor endothelial cells migration.
Ghilardi C, Anastasia A, Avigni R, Lupi M, Giavazzi R, Bani MR.
Thromb Res 140 Suppl 1:S192-3. doi: 10.1016/S0049-3848(16)30177-3. Epub 2016 Apr 8. 2016
3PRSS3
Trypsinogen 4 boosts tumor endothelial cells migration through proteolysis of tissue factor pathway inhibitor-2.
Ghilardi C, Silini A, Figini S, Anastasia A, Lupi M, Fruscio R, Giavazzi R, Bani MR.
Oncotarget 6(29):28389-400. doi: 10.18632/oncotarget.4949. 2015
4PRSS3, TFPI2
Trypsinogen 4 boosts tumor endothelial cells migration through proteolysis of tissue factor pathway inhibitor-2.
Ghilardi C, Silini A, Figini S, Anastasia A, Lupi M, Fruscio R, Giavazzi R, Bani MR.
Oncotarget 6(29):28389-400. doi: 10.18632/oncotarget.4949. 2015
5PRSS3
PRSS3 expression is associated with tumor progression and poor prognosis in epithelial ovarian cancer.
Ma R, Ye X, Cheng H, Ma Y, Cui H, Chang X.
Gynecol Oncol 137(3):546-52. doi: 10.1016/j.ygyno.2015.02.022. Epub 2015 Feb 28. 2015
6CASP14, PRSS3, PSAP
Mesotrypsin and caspase-14 participate in prosaposin processing: potential relevance to epidermal permeability barrier formation.
Yamamoto-Tanaka M, Motoyama A, Miyai M, Matsunaga Y, Matsuda J, Tsuboi R, Hibino T.
J Biol Chem 289(29):20026-38. doi: 10.1074/jbc.M113.543421. Epub 2014 May 28. 2014
7PRSS3, TFPI2
Mesotrypsin and caspase-14 participate in prosaposin processing: potential relevance to epidermal permeability barrier formation.
Yamamoto-Tanaka M, Motoyama A, Miyai M, Matsunaga Y, Matsuda J, Tsuboi R, Hibino T.
J Biol Chem 289(29):20026-38. doi: 10.1074/jbc.M113.543421. Epub 2014 May 28. 2014
8PRSS3, SPINK5
Keratinocyte-specific mesotrypsin contributes to the desquamation process via kallikrein activation and LEKTI degradation.
Miyai M, Matsumoto Y, Yamanishi H, Yamamoto-Tanaka M, Tsuboi R, Hibino T.
J Invest Dermatol 134(6):1665-1674. doi: 10.1038/jid.2014.3. Epub 2014 Jan 3. 2014
9F2RL1, PRSS3
Autocrine extra-pancreatic trypsin 3 secretion promotes cell proliferation and survival in esophageal adenocarcinoma.
Han S, Lee CW, Trevino JG, Hughes SJ, Sarosi GA Jr.
PLoS One 8(10):e76667. doi: 10.1371/journal.pone.0076667. eCollection 2013. 2013
10PRSS3
PRSS3/mesotrypsin is a therapeutic target for metastatic prostate cancer.
Hockla A, Miller E, Salameh MA, Copland JA, Radisky DC, Radisky ES.
Mol Cancer Res 10(12):1555-66. doi: 10.1158/1541-7786.MCR-12-0314. 2012
11PRSS3
PRSS3 promotes tumour growth and metastasis of human pancreatic cancer.
Jiang G, Cao F, Ren G, Gao D, Bhakta V, Zhang Y, Cao H, Dong Z, Zang W, Zhang S, Wong HH, Hiley C, Crnogorac-Jurcevic T, Lemoine NR, Wang Y.
Gut 59(11):1535-44. doi: 10.1136/gut.2009.200105. 2010
12PRSS3
Keratinocytes synthesize enteropeptidase and multiple forms of trypsinogen during terminal differentiation.
Nakanishi J, Yamamoto M, Koyama J, Sato J, Hibino T.
J Invest Dermatol 130(4):944-52. doi: 10.1038/jid.2009.364. Epub 2009 Nov 19. 2010
13PRSS3
The amyloid precursor protein/protease nexin 2 Kunitz inhibitor domain is a highly specific substrate of mesotrypsin.
Salameh MA, Robinson JL, Navaneetham D, Sinha D, Madden BJ, Walsh PN, Radisky ES.
J Biol Chem 285(3):1939-49. doi: 10.1074/jbc.M109.057216. Epub 2009 Nov 17. 2010
14PRSS3
Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients.
Kerckhoffs AP, Ter Linde JJ, Akkermans LM, Samsom M.
Neurogastroenterol Motil 20(8):900-7. doi: 10.1111/j.1365-2982.2008.01100.x. Epub 2008 Mar 7. 2008
15PRSS3
Regional distribution of human trypsinogen 4 in human brain at mRNA and protein level.
Tóth J, Siklódi E, Medveczky P, Gallatz K, Németh P, Szilágyi L, Gráf L, Palkovits M.
Neurochem Res 32(9):1423-33. Epub 2007 Apr 4. 2007
16PRSS3
Human mesotrypsin exhibits restricted S1' subsite specificity with a strong preference for small polar side chains.
Szepessy E, Sahin-Tóth M.
FEBS J 273(13):2942-54. Epub 2006 Jun 5. 2006
17PRSS3
Epigenetic silencing of the PRSS3 putative tumor suppressor gene in non-small cell lung cancer.
Marsit CJ, Okpukpara C, Danaee H, Kelsey KT.
Mol Carcinog 44(2):146-50. 2005
18PRSS3
Human mesotrypsin is a unique digestive protease specialized for the degradation of trypsin inhibitors.
Szmola R, Kukor Z, Sahin-Tóth M.
J Biol Chem 278(49):48580-9. Epub 2003 Sep 24. 2003
19PRSS1, PRSS2, PRSS3, PRSS3P2, TRB@, TRBC2, TRBD1, TRBD2, TRBJ1-1, TRBJ1-2, TRBJ1-3, TRBJ1-4, TRBJ1-5, TRBJ1-6, TRBJ2-1, TRBJ2-2, TRBJ2-2P, TRBJ2-3, TRBJ2-4, TRBJ2-5, TRBJ2-6, TRBJ2-7, TRBJ@, TRBV1, TRBV10-1, TRBV10-2, TRBV10-3, TRBV11-1, TRBV11-2, TRBV11-3, TRBV12-1, TRBV12-2, TRBV12-3, TRBV12-4, TRBV12-5, TRBV13, TRBV14, TRBV15, TRBV16, TRBV17, TRBV18, TRBV19, TRBV2, TRBV20-1, TRBV21-1, TRBV22, TRBV22, TRBV23-1, TRBV24-1, TRBV25-1, TRBV26, TRBV27, TRBV28, TRBV29-1, TRBV3-1, TRBV3-2, TRBV30, TRBV4-1, TRBV4-2, TRBV4-3, TRBV5-1, TRBV5-2, TRBV5-3, TRBV5-4, TRBV5-5, TRBV5-6, TRBV5-7, TRBV5-8, TRBV6-1, TRBV6-2, TRBV6-3, TRBV6-4, TRBV6-5, TRBV6-6, TRBV6-7, TRBV6-8, TRBV6-9, TRBV7-1, TRBV7-2, TRBV7-4, TRBV7-5, TRBV7-6, TRBV7-7, TRBV7-8, TRBV7-9, TRBV8-1, TRBV8-2, TRBV9, TRBV@, TRBVA, TRBVB, TRY7
The complete 685-kilobase DNA sequence of the human beta T cell receptor locus.
Rowen L, Koop BF, Hood L.
Science 272(5269):1755-62. 1996
20PRSS3
Cloning of the cDNA encoding human brain trypsinogen and characterization of its product.
Wiegand U, Corbach S, Minn A, Kang J, Muller-Hill B.
Gene 136 : 167-175. 1993
21PRSS3
Nucleotide sequence of the human pancreatic trypsinogen III cDNA.
Tani T, Kawashima I, Mita K, Takiguchi Y.
Nucleic Acids Res 18(6):1631. 1990